Umbilical Cord Cells
The umbilical cord is a unique perinatal tissue containing diverse vascular, stromal, hematopoietic, and progenitor cell populations. Because these cells are developmentally young, highly proliferative, and readily accessible, they have become indispensable tools for vascular biology, stem cell research, regenerative medicine, immunology, and cell therapy development.
Our umbilical cord cell portfolio includes endothelial cells, smooth muscle cells, Wharton's Jelly-derived cells, cord blood mononuclear cells, CD34+ and CD133+ progenitor cells, as well as specialized fluorescently labeled endothelial cell models. These products support a broad range of applications including angiogenesis studies, vascular disease modeling, immunotherapy research, stem cell biology, and advanced cell engineering programs.
Filter By:
Our Umbilical Cord Cell Portfolio Highlights
-
Vascular Cell Models
- Umbilical vein and artery endothelial cells
- Umbilical artery and vein smooth muscle cells
- Fluorescently labeled endothelial cell models
-
Cord Blood Cell Resources
- Cord blood mononuclear cells
- NK cells, monocytes, and neutrophils
- Immune and hematopoietic cell populations
-
Progenitor & Stem Cell Populations
- CD34+ progenitor cells
- CD133+ stem/progenitor cells
- Wharton's Jelly-derived umbilical cord cells
-
Angiogenesis & Vascular Biology
Investigate endothelial function, vascular remodeling, permeability, and blood vessel formation using primary umbilical vascular cells.
-
Stem Cell & Regenerative Medicine Research
Explore progenitor cell biology, tissue regeneration, cell differentiation, and translational regenerative medicine applications.
-
Immunology & Cell Therapy Development
Utilize cord blood-derived immune cells for immune profiling, cell therapy research, and immunomodulation studies.
-
Cell Engineering & Live Cell Imaging
Leverage GFP-, RFP-, and biosensor-expressing endothelial cell models for mechanistic studies and advanced imaging applications.
Why are HUVECs widely used in biomedical research?
Human Umbilical Vein Endothelial Cells (HUVECs) are one of the most extensively characterized endothelial models and are commonly used to study angiogenesis, vascular permeability, inflammation, endothelial signaling, and drug responses.
What advantages do cord blood-derived progenitor cells offer?
CD34+ and CD133+ cord blood cells possess strong proliferative potential and are frequently used in hematopoietic stem cell research, regenerative medicine, and cell therapy development.
What are Wharton's Jelly cells commonly used for?
Wharton's Jelly-derived cells are valuable for regenerative medicine studies, tissue engineering applications, extracellular vesicle research, and investigations of cell-mediated repair mechanisms.
Why are fluorescently labeled endothelial cells useful?
GFP-, RFP-, and biosensor-expressing endothelial cells enable real-time visualization of cell migration, angiogenesis, calcium signaling, intracellular trafficking, and other dynamic cellular processes.
Can cord blood immune cells support immunotherapy research?
Yes. Cord blood-derived NK cells, monocytes, and mononuclear cells are widely used for immune profiling, adoptive cell therapy development, cytokine studies, and immune engineering applications.
How can umbilical cord-derived cells be incorporated into advanced in vitro models?
Researchers frequently combine endothelial, smooth muscle, stromal, and progenitor cell populations to create vascularized tissue models, organ-on-chip systems, and multicellular microenvironment platforms.